Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026
Generation Bio Co. Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 21.94 | 76.3 | 66.45 | 93.17 | 375.15 | 62.89 |
Short-Term Investments | 67.68 | 108.92 | 197.92 | 185.92 | - | 199.44 |
Cash & Short-Term Investments | 89.62 | 185.22 | 264.36 | 279.09 | 375.15 | 262.33 |
Cash Growth | -55.15% | -29.94% | -5.28% | -25.60% | 43.01% | 1640.03% |
Accounts Receivable | 0.39 | 1.22 | 3.96 | 0.4 | - | - |
Other Current Assets | 3.45 | 6.46 | 4.29 | 7.53 | 4.04 | 5.41 |
Total Current Assets | 93.46 | 192.9 | 272.62 | 287.02 | 379.19 | 267.74 |
Net Property, Plant & Equipment | 26.28 | 35.6 | 95.65 | 81.42 | 91.03 | 23.78 |
Other Long-Term Assets | 2.15 | 2.69 | 6.49 | 7.83 | 6.56 | 2.64 |
Total Assets | 121.9 | 231.2 | 374.76 | 376.26 | 476.77 | 294.16 |
Accounts Payable | 2.06 | 1.41 | 2.35 | 0.66 | 2.02 | 0.27 |
Accrued Expenses | 12.48 | 10.06 | 16.53 | 11.4 | 12.18 | 10.95 |
Current Portion of Leases | 6.35 | 13.01 | 8.12 | 7.09 | 4.61 | - |
Unearned Revenue | 0.15 | 10.58 | 12.92 | - | - | - |
Total Current Liabilities | 21.04 | 35.06 | 39.91 | 19.15 | 18.81 | 11.22 |
Long-Term Leases | 19.74 | 80.55 | 89.77 | 74.62 | 76.22 | - |
Other Long-Term Liabilities | 30.55 | 29.38 | 41.94 | - | - | 14.92 |
Total Long-Term Liabilities | 50.3 | 109.94 | 131.72 | 74.62 | 76.22 | 14.92 |
Total Liabilities | 71.34 | 144.99 | 171.63 | 93.77 | 95.03 | 26.14 |
Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 794.84 | 789.09 | 774.22 | 727.34 | 689.87 | 456.97 |
Accumulated Other Comprehensive Income | 0.01 | 0.16 | 0.27 | -0.08 | - | 0.01 |
Retained Earnings | -744.29 | -703.05 | -571.38 | -444.77 | -308.13 | -188.98 |
Total Common Shareholders' Equity | 50.56 | 86.2 | 203.13 | 282.49 | 381.75 | 268.01 |
Shareholders' Equity | 50.56 | 86.2 | 203.13 | 282.49 | 381.75 | 268.01 |
Total Liabilities & Equity | 121.9 | 231.2 | 374.76 | 376.26 | 476.77 | 294.16 |
Total Debt | 26.1 | 93.56 | 97.89 | 81.71 | 80.83 | 0 |
Net Cash (Debt) | 63.53 | 91.66 | 166.47 | 197.38 | 294.32 | 262.33 |
Net Cash Growth | -30.70% | -44.94% | -15.66% | -32.94% | 12.20% | 1640.03% |
Net Cash Per Share | 9.47 | 13.76 | 25.82 | 33.96 | 52.28 | 96.24 |
Book Value | 50.56 | 86.2 | 203.13 | 282.49 | 381.75 | 268.01 |
Book Value Per Share | 7.54 | 12.94 | 31.50 | 48.61 | 67.81 | 98.33 |
Tangible Book Value | 50.56 | 86.2 | 203.13 | 282.49 | 381.75 | 268.01 |
Tangible Book Value Per Share | 7.54 | 12.94 | 31.50 | 48.61 | 67.81 | 98.33 |